Regulatory Treatment of Contradictory Scientific Models

Introduction

Contradictory scientific models arise when different scientific methods, assumptions or analytical frameworks produce conflicting predictions about the safety, efficacy or environmental impact of a regulated product or activity. In biotechnology, such conflicts may concern gene-editing technologies, genetically modified crops, biological medicines, vaccine safety, ecological risk or clinical-trial outcomes.

A scientific model is a simplified representation of a complex biological or environmental system. Models may differ because they use different datasets, assumptions, variables, statistical methods or definitions of risk. Therefore, disagreement between models does not automatically establish that one model is false or that the regulated product is unsafe.

Regulatory authorities must evaluate competing models through a transparent, evidence-based and legally accountable process. Their responsibility is to determine which model is sufficiently reliable for the regulatory question, whether further evidence is necessary and what safeguards are proportionate to the identified uncertainty.

Legal Principles and Regulatory Response

A legally sound response to contradictory models should include:

Comparative evaluation: Assess each model’s assumptions, data sources, validation, limitations and relevance to the regulatory question.

Independent expert review: Seek independent scientific advice where competing models materially affect risk conclusions.

Precautionary assessment: Do not treat absence of consensus as proof of either safety or danger. Consider uncertainty and possible consequences.

Further testing: Request confirmatory studies, alternative modelling, field data or additional validation when the evidence is insufficient.

Reasoned decision-making: Explain why a model was accepted, rejected or given limited weight.

Proportionate safeguards: Consider conditional approval, monitoring, restricted use or suspension depending on the seriousness and uncertainty of the risk.

The regulator’s task is not necessarily to choose one model as universally correct. It is to determine which model is fit for the particular decision and whether remaining uncertainty can be managed lawfully.

Relevant Case Laws

1. N.D. Jayal v. Union of India, (2004) 9 SCC 362

The Supreme Court considered expert disagreement regarding the safety of the Tehri Dam project. It recognised that experts may differ in scientific opinions, but opposing viewpoints must receive due consideration. Courts should generally avoid substituting their own scientific assessment for that of competent authorities, unless the decision is arbitrary, based on irrelevant considerations or fails to consider material evidence. This is a central principle for regulatory treatment of competing scientific models.

VoxJuris

2. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court considered competing scientific assessments and expert opinions concerning genetically modified mustard, DMH-11. The judgments reflected disagreement over the regulatory approval, and the matter was directed to be reconsidered by an appropriate Bench. The Court also recognised that GMO regulatory decisions are subject to judicial review and directed development of a national policy with stakeholder consultation. The case demonstrates that contradictory scientific assessments must be addressed through transparent, legally accountable processes rather than treated as automatically resolved by one expert opinion.

Sci API+1

3. Jacob Puliyel v. Union of India, 2022 SCC OnLine SC 533

The Supreme Court considered vaccine safety and competing scientific opinions during the COVID-19 pandemic. It emphasised the role of scientific evidence and expert regulatory assessment. The decision supports deference to informed regulatory judgment, but does not shield decisions that disregard relevant evidence or act arbitrarily.

These authorities provide general principles for scientific disagreement and regulatory review. They do not prescribe a universal mathematical or technical method for choosing between all competing scientific models.

Conclusion

Contradictory scientific models require careful evaluation of assumptions, data quality, validation and uncertainty. Regulators must consider material competing views, seek expert review where necessary and provide reasons for their conclusions. Courts generally respect informed scientific decisions while retaining power to review arbitrariness, procedural defects and failure to consider relevant evidence.

The governing principle is scientific disagreement must be managed through rigorous assessment, transparency and proportionate regulatory action—not by blindly accepting one model or treating uncertainty as proof of safety or harm.